Document is current
Any future updates will be listed below
-
Authors
Aronson, Julia
Bhatta, Manasa
Carey, Lisa A.
Jobanputra, Kunal
Gupta, Gaorav P.
Abdou, Yara
- License Information
-
More Information
Article History
Received: 3 June 2025
Accepted: 31 July 2025
First Online: 16 August 2025
Competing interests
: Y.A. received consultant fees from Pfizer and AstraZeneca outside of submitted work. G.P.G. receives patent licensing fees from and has equity in Naveris, Inc., and is the recipient of research funding from Breakpoint Therapeutics and Merck outside of submitted work. L.A.C. receives research support from NanoString Technologies, Seattle Genetics, Veracyte, Gilead, Novartis, Lilly, Pfizer, and AstraZeneca outside of submitted work. J.A., M.B., and K.J. declare no competing interests.
